The aim of the Transplant Complications Working Party is to conduct research as well as provide education and expertise on the subject of non-infectious complications after hematopoietic cell transplantation. The major fields of interest of the TCWP are:
- Early complications e.g. graft failure, VOD/SOS, transplant-associated microangiopathy (TAM), other endothelial syndromes, impact of co-morbidities, toxicity of conditioning regimen and supportive care;
- Acute and chronic graft versus host disease – all the aspects from risk factors through diagnosis to treatment;
- Late effects – e.g. infertility, sexual dysfunction, secondary cancers, organ-specific late complications, quality of life.
The TCWP is a transversal Working Party, covering complications occurring after transplantation for all the indications. Therefore, its performance is strictly related to collaboration with disease-specific working parties, and studies directly dedicated to non-infectious complications should be performed either in or in close collaboration with TCWP.
To submit a proposal to the TCWP for a new study, download the following documents:
Patients who underwent HSCT, both allogeneic or autologous, between January 1st, 2021 and December 31st, 2022 and developed an infectious (any CTCAE grade) or relevant (CTCAE >1°) non-infectious CNS disorder after HSCT in this period can be included in this study. If you'd like to receive more information, or if you have an eligible patient, please contact the IDWP data office (email can be found below) and we will send you the registration form and all other required information to join our study.
TCWP Publications List
Guidelines, Consensus Statements, and Position Papers
Open calls to participate in a new study
The Transplant Complications Working Party is currently overseeing the following studies.
SFAST: A cross-sectional study on the sexual function of adult survivors and their partners 3 and 15 years post allogeneic stem cell transplantation
PI: Corien Eeltink
Complications of haploidentical HCT with post-transplant cyclophosphamide - a non-interventional prospective study
PI: Grzegorz Basak
NIS: EASIX to predict alloSCT outcome
PIs: Olaf Penack and Thomas Luft
Fecal microbiota transplantation in the treatment of graft-versus-host disease – retrospective survey
PI: Jarosław Biliński
Current practice in vitamin D assessment and management across the Adult and Paediatric Haematopoietic Stem Cell Transplant Centres in Europe (SUNSHINE).
PI: Jose Ros-Soto
Late effects after hematopoietic stem cell transplantation in patients with HLH.
PI: Anna Carin-Horne